Catherine Coste
CIK 1821432 · last filed 2026-02-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$644.7K
Companies
4
Total Filings
12
Lifetime Open-Market Net
$56.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BLFS | Director | 13,871 | $26.10 | $362.0K | $0 | 2 | 2026-02-26 |
| BMRA | Director | 137,890 | $2.05 | $282.7K | $56.1K | 7 | 2024-12-17 |
| Renalytix plc (RNLX) Delisted | Director | — | $0.21 | — | $0 | 2 | 2023-11-22 |
| UTRS | Director | 129,579 | $0.00 | $13 | $0 | 1 | 2022-06-14 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-12-11 | BMRA | Grant (A) | — | $0 | EDGAR |
| 2020-10-27 | BMRA | Buy (P) | +9,100 | $49.6K | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.